GreyBird Ventures - aVenture Asset Manager Research
Location
Concord, MA, US
Founded
2013
GreyBird Ventures is an early-stage venture capital firm focused on precision medicine diagnostics. The firm invests in companies developing innovative technologies for accurate medical diagnosis, primarily in the Series A stage. GreyBird's investment strategy centers on supporting advancements in the rapidly evolving field of precision medicine.
Notable portfolio companies include Angstrom Bio, Atlas5D, and Ceres Nanosciences. GreyBird Ventures adds value to its investments by leveraging deep industry expertise in medical technology and diagnostics. The firm's commitment to precision medicine is evident in its partnerships, such as the collaboration between portfolio company Genetika+ and GEHA Mental Health Center to drive innovation in depression treatment.
GreyBird Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A2 (66.7%)
Seed1 (33.3%)
Stage Mix
Series A 67%Seed 33%
Concentration shown as share of disclosed investments by stage.